Status:
ACTIVE_NOT_RECRUITING
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Cervical Cancer
Human Papillomavirus Infection
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. This study is a supplement to increase represent...
Detailed Description
Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. Using mailed self-sampling kits to test for high...
Eligibility Criteria
Inclusion
- Asian ethnicity reported in the electronic health record
- no history of hysterectomy or cervical cancer
- no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
- patient of Harris Health System in Harris County (Houston), Texas
- have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
- be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months
Exclusion
- no valid telephone contact information
- unable to communicate in English, Vietnamese or Spanish
- currently pregnant
- history of cervical dysplasia in the past 3.5 years
Key Trial Info
Start Date :
September 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2026
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT06577220
Start Date
September 28 2023
End Date
January 24 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harris Health System
Houston, Texas, United States, 77030